within Pharmacolibrary.Drugs.R_RespiratorySystem.R01B_NasalDecongestantsForSystemicUse.R01BA02_Pseudoephedrine;

model Pseudoephedrine
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.9,
    Cl = 8.75e-06,
    adminDuration = 600,
    adminMass = 60 / 1000000,
    adminCount = 1,
    Vd = 0.0026,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.016666666666666666,
    Tlag = 9.96);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Pseudoephedrine</td></tr><tr><td>ATC code:</td><td>R01BA02</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>60</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>2.6</td><td>L</td></tr>
    <tr><td>clearance:</td><td>7.5</td><td>mL/min/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Pseudoephedrine is a sympathomimetic drug primarily used as a nasal decongestant for the temporary relief of nasal congestion due to colds, allergies, or sinusitis. It is available over-the-counter in many countries and remains widely used, though its sale is restricted due to its potential use in illicit methamphetamine synthesis.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after single oral dose of pseudoephedrine hydrochloride.</p><h4>References</h4><ol><li><p>Howard, DR, et al., &amp; Agrawala, P (2005). Single-dose and steady-state bioequivalence of fexofenadine and pseudoephedrine combination tablets compared with individual formulations in healthy adults. <i>Current medical research and opinion</i> 21(5) 769–776. DOI:<a href=\"https://doi.org/10.1185/030079905x43703\">10.1185/030079905x43703</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15969876/\">https://pubmed.ncbi.nlm.nih.gov/15969876</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.R.R01BA02 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Pseudoephedrine;
